<DOC>
	<DOCNO>NCT02629822</DOCNO>
	<brief_summary>The primary objective study evaluate antiretroviral activity evaluate safety tolerability open-label MK-1439A consist single fixed-dose combination ( FDC ) tablet MK-1439 100 mg/lamivudine 300 mg/tenofovir disoproxil fumarate 300 mg treatment-naive HIV-1 infect participant select NNRTI transmit resistance mutation .</brief_summary>
	<brief_title>Safety Efficacy MK-1439A Participants Infected With Treatment-Naïve Human Immunodeficiency Virus ( HIV ) -1 With Transmitted Resistance ( MK-1439A-030 )</brief_title>
	<detailed_description />
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<mesh_term>Reverse Transcriptase Inhibitors</mesh_term>
	<criteria>Is HIV1 positive within 45 day prior treatment phase study , HIV treatment indicate base physician assessment . Is naïve antiretroviral therapy ( ART ) include investigational antiretroviral agent . Prior screening , genotype perform confirm presence one follow NNRTI mutation : K103N , Y181C , G190A . Is consider clinically stable sign symptom active infection time entry study ( i.e . clinical status chronic medication unchanged least 2 week prior start treatment study ) . Is highly unlikely become pregnant impregnate partner Is user recreational illicit drug recent history drug alcohol abuse dependence . Has treat viral infection HIV1 , hepatitis B , agent active HIV1 , include , limited , adefovir , tenofovir , entecavir , emtricitabine , lamivudine . Has document know resistance study drug ( MK1439 , lamivudine , and/or tenofovir ) Has participate anticipates participate study investigational compound/device within 30 day prior sign inform consent Has medical condition requiring , likely require , chronic systemic administration corticosteroid , tumor necrosis factor ( TNF ) antagonists , immunosuppressant drug course trial . Requires anticipate require prohibit medication Has significant hypersensitivity contraindication component study drug Has current ( active ) diagnosis acute hepatitis due cause Has evidence decompensated liver disease liver cirrhosis ChildPugh Class C score PughTurcotte ( CPT ) score &gt; 9 Is pregnant , breastfeeding , expect conceive Is female expect donate egg , male expect donate sperm time study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>